The IL-33/ST2 pathway to modulate the inflammatory microenvironment: A new therapeutic target in chronic obstructive pulmonary disease
Xiaoyan Xie, Lei Yang, Jie Chen, Yonghong Wu, Jingjing Zhong, Hao Shen, Gaofeng Zheng · 2026
Read The IL-33/ST2 pathway to modulate the inflammatory microenvironment: A new therapeutic target in chronic obstructive pulmonary disease by Xiaoyan Xie, Lei Yang, Jie Chen, Yonghong Wu, Jingjing Zhong, Hao Shen, Gaofeng Zheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13311994.txt.
Description
Xiaoyan Xie and co-authors review the IL-33/ST2 signaling pathway as a drug target in chronic obstructive pulmonary disease in a 2026 article. The pathway weaves through oxidative stress, immunity, and lung injury.
Levels of IL-33 and its receptor ST2 run high in patients and track with worse disease, more flare-ups, and poorer outcomes, on the reviewed evidence. Blocking antibodies and receptor inhibitors have calmed inflammation and improved lung function in early studies. How the pathway talks with other inflammatory circuits is still murky. The review maps the biology and the drug pipeline aimed at it.
Catalog record
| CREATOR | Xiaoyan Xie, Lei Yang, Jie Chen, Yonghong Wu, Jingjing Zhong, Hao Shen, Gaofeng Zheng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32548 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |